IL4 and cancer: A chimeric protein composed of human IL-4 and a full-length PE molecule with mutation in the cell binding domain of PE, hIL4-PE4E, was cytotoxic (with 50% inhibition of protein synthesis [IC50] occurring in the 12–120-pM range) to a wide range of human cancer cell lines [69, 70].